On this episode of Denatured, Lori Ellis and guests discuss President Biden’s Executive Order on Advancing Women’s Health Research and Innovation and the outlook of investment in women’s health.
12 billion dollars: one of the boldest women’s health research moves an administration has made for women’s health research. On a global scale, this has caused countries and sovereign states to start investing in women’s health.
But in the United States, the funding is not guaranteed. It depends on congressional approval, which is complicated during an election year. As the United States continues to grapple with politics and science meeting, the global healthcare sector is already beginning to reframe the language and invest in women’s health research.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Sans Thakur, Founder and Chairwoman of Tower Capital
Chia Chia Sun, Chief Commercial Officer at Fab Biopharma
Elisa Cascade, Chief Product Officer of at Advarra
Shawana Moore, Medical Advisor on the Advisory Council for Healthy Women
Katie Schubert, President and Chief Executive Officer of the Society for Women’s Health
